{
    "Trade/Device Name(s)": [
        "illumigene\u00ae Group B Streptococcus (GBS) DNA Amplification Assay",
        "illumigene Group B Streptococcus (GBS) DNA Amplification Assay"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K121044",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112125"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NJR"
    ],
    "Summary Letter Date": "April 5, 2012",
    "Summary Letter Received Date": "April 6, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3740"
    ],
    "Regulation Name(s)": [
        "Streptococcus spp. serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Streptococcus agalactiae genome segment"
    ],
    "Specimen Type(s)": [
        "Vaginal/rectal swab (enriched culture)"
    ],
    "Specimen Container(s)": [
        "Lim Broth",
        "TransVag Broth",
        "Carrot Broth"
    ],
    "Instrument(s)/Platform(s)": [
        "illumipro-10 Automated Isothermal Amplification and Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Loop-mediated isothermal DNA amplification (LAMP)",
        "DNA amplification assay"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Isothermal amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for illumigene Group B Streptococcus (GBS) DNA Amplification Assay using isothermal DNA amplification for qualitative detection of Streptococcus agalactiae in enriched vaginal/rectal swab cultures.",
    "Indications for Use Summary": "Qualitative detection of Streptococcus agalactiae from enriched vaginal/rectal swab specimens collected from antepartum women, to aid in establishing GBS colonization status; not for diagnosis, treatment monitoring, or point-of-care use.",
    "fda_folder": "Microbiology"
}